Quotient Sciences

PHILADELPHIA, PA — Quotient Sciences announced an expanded commercial supply partnership with Ipsen to manufacture Sohonos (palovarotene), a treatment for Fibrodysplasia Ossificans Progressiva, an ultra-rare disease affecting fewer than 1,000 …